Merck & Company Inc (MRK) financials · P/E 116, rev $65.01B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Merck & Company Inc (MRK) P/E 116, rev $65.01B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $65.01B | $64.17B |
| Cost of Revenue | $16.38B | $15.19B |
| Gross Profit | $48.63B | $48.98B |
| Net Income | $18.25B | $17.12B |
| EPS (Diluted) | $7.28 | $6.74 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $136.87B | $117.11B |
| Current Assets | $43.52B | $38.78B |
| Cash & Equivalents | $14.56B | $13.24B |
| Inventory | $6.66B | $6.11B |
| PP&E | $25.32B | $23.78B |
| Total Liabilities | $84.26B | $70.79B |
| Current Liabilities | $28.33B | $28.42B |
| Short-term Debt | $2.59B | $2.65B |
| Long-term Debt | $46.75B | $34.46B |
| Total Debt | $49.34B† | $37.11B† |
| Shareholders' Equity | $52.61B | $46.31B |
| Retained Earnings | $73.08B | $63.07B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $16.47B | $21.47B |
| CapEx | $4.11B | $3.37B |
| Investing Cash Flow | -$13.74B | -$7.73B |
| Financing Cash Flow | -$1.92B | -$7.03B |
| Dividends Paid | $8.18B | $7.84B |
| Net Change in Cash | $1.37B | $6.41B |
| Free Cash Flow | $12.36B | $18.10B |
FAQ
What is MRK P/E and revenue?
Merck & Company Inc (MRK) P/E 116, rev $65.01B.
What is MRK revenue?
Merck & Company Inc last cached revenue is $65.01B (FY2025).
Is MRK profitable?
Merck & Company Inc last cached net income is $18.25B (FY2025).
What are MRK total assets?
Merck & Company Inc last cached total assets are $136.87B (FY2025).
What is MRK free cash flow?
Merck & Company Inc last cached free cash flow is $12.36B (FY2025).
Not investment advice. Cached statements, not a live tape.